HOME >> MEDICINE >> NEWS
Promising Bone Cancer Therapy Advances To Next Level

Encouraging initial results, clinical trial report presented at national meeting

UPTON, NY -- More than 400,000 Americans with advanced-stage bone cancer may one day find non-sedating relief for their excruciating bone pain -- and possible treatment for their cancer -- in a promising therapy now being tested in a nationwide clinical trial.

The newly patented nuclear medicine therapy, based on a compound called tin-117m DTPA, was developed at the U.S. Department of Energy's Brookhaven National Laboratory.

"In preliminary clinical trials involving 47 patients, we showed that it totally or significantly eased the pain of more than 75 percent of patients, relief that lasted for up to a year and produced no side effects," said Brookhaven scientist Suresh Srivastava, co-developer of the therapy.

Srivastava presented those findings and an outlook for the therapy's future today at the American College of Nuclear Physicians' annual scientific meeting in Hawaii.

He also described the current nationwide clinical trial, designed to test the compound's potency in giving pain relief to patients whose cancer has spread to the bone.

Diatide Inc., a New Hampshire biotechnology company that has licensed the technology from BNL, is sponsoring and coordinating the multicenter trial, which will include 100 prostate cancer patients and 75 patients with other cancers. Patients are still being accepted at the participating hospitals, and may call Diatide at 603-621-7574 for more information.

"Based on this promising start, we're now investigating whether our approach may actually help shrink cancer lesions that have spread to the bone, in addition to relieving the pain they cause," Srivastava said. "And, we're pursuing preliminary research on its use in treating primary bone cancer and rheumatoid arthritis."

A New Option for Bone Cancer Pain
Bone cancer is a dreaded sec
'"/>

Contact: Kara Villamil
karav@bnl.gov
516-344-5658
DOE/Brookhaven National Laboratory
18-Feb-1999


Page: 1 2 3

Related medicine news :

1. Promising new strategy for Swedish medical research
2. Promising treatments for Huntingtons disease identified in UCI study
3. Promising results for malaria vaccine trial
4. Promising diagnostic test for sleeping sickness
5. Promising new treatment options for people with co-existing alcohol-use and psychiatric disorders
6. Promising drug fails to thwart fatal lung disease in large trial
7. Promising drug proves ineffective as treatment for hearing loss
8. Promising West Nile virus vaccine protects monkeys
9. Promising new treatment preserves bone mass in mice; May help women and men with osteoporosis
10. Promising vaccine may provide long-lasting protection against malaria
11. Promising new research on schizophrenia causes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... ... , ... Becker's Healthcare is pleased to recognize the following ... women included on this list lead organizations regularly recognized for patient safety and ... the construction of satellite clinics and strategic partnerships with local healthcare organizations. These ...
(Date:7/17/2019)... ... 2019 , ... This past Saturday, Monarch Dental® hosted a luau-themed ... 50 underserved patients were welcomed at the Mesquite office to receive free cleanings ... Individuals were referred to the event through local nonprofit organizations such as Minnie’s ...
(Date:7/17/2019)... ... ... A medical home care program found that having a single accessible point person ... While this may not sound surprising, a recent two year medical home pilot study ... uncovered several surprising outcomes based on a simple formatted healthcare delivery system. , ...
(Date:7/13/2019)... ... July 13, 2019 , ... ZALO , the leading ... innovative rechargeable vibrator and clitoral massager. To view the product and its accompanying video ... and most advanced, personal massagers to people around the world,” said Mara Epstein, director ...
(Date:7/13/2019)... ... July 12, 2019 , ... China Focus @ ... , sponsored by Hangzhou Investment Promotion Bureau, Fox Rothschild LLP, MORE Health and ... conference attracted Fosun Pharmaceuticals, WuXi Biologics, Kelun Pharmaceutical, Harbin Pharmaceuticals, Fountain Medical, Luye ...
Breaking Medicine News(10 mins):
(Date:7/17/2019)... ... July 17, 2019 , ... ... MDA for their fourth annual national “Be Their Muscle” philanthropic event, and seventh ... lives of kids and adults with muscular dystrophy, ALS and related neuromuscular diseases ...
(Date:7/17/2019)... ... July 17, 2019 , ... Gwinnett Family Dental ... and trusted provider of complete dental care, including general and preventative care as well ... with a large team of extensively trained dentists, Dr. Kell Gallaher, Dr. Jon Klevansky, ...
(Date:7/17/2019)... ... July 17, 2019 , ... Cognition Corporation , ... a new e-book on developing user needs for life science products. ... a small part of the compliance process and the guiding force for product ...
Breaking Medicine Technology:
Cached News: